Triona Zelesnik PhD

Triona has 10 years’ experience in pharmaceutical asset and portfolio strategy, predominately in the EU and US markets. She is an expert in integrated evidence strategy and early real world evidence planning to ensure successful product launches

Following completion of her PhD in development craniofacial biology, Triona spent 7 years working in pharmaceutical brand and strategy consulting. She then pivoted to focus on integrated evidence planning, with particular interest in the importance of early anticipation of real world evidence requirements for multiple stakeholders types to deliver peri- and post-launch success.

Triona is passionate about understanding the importance of detailed and nuanced patient care pathway in driving brand strategy, market access and evidence planning decisions. With cross-indication experience, Triona has specific experience with immunology, solid tumor oncology, and endocrinology.